Skip to main content
. 2021 Jun 2;114(4):503–516. doi: 10.1093/jnci/djab106

Figure 4.

Figure 4.

Forest plots of hazard ratios (HRs) for the predictive value of the consensus molecular subtypes (CMSs) for adjuvant chemotherapy in colorectal cancer. A) Overall survival for adjuvant chemotherapy vs surgery alone. B) Relapse-free survival for adjuvant chemotherapy vs surgery alone. C) Relapse-free survival for oxaliplatin plus 5-fluorouracil and leucovorin vs 5-fluorouracil plus leucovorin. aImmunohistochemistry classification: CMS2 and CMS3 depicted as CMS2. 5-FU = 5-fluorouracil; FOLFOX = 5-fluorouracil, leucovorin, and oxaliplatin; FULV = 5-fluorouracil and leucovorin.